Valacyclovir is considered safe for long-term use, and most people on daily suppressive therapy tolerate it well for years. The CDC notes that adverse events related to long-term use are uncommon and that routine laboratory monitoring isn’t even necessary if baseline blood work is normal. That said, there are real side effects worth knowing about, particularly involving the kidneys, the nervous system, and the liver.
Kidney Problems Are the Primary Concern
The kidneys do most of the heavy lifting when it comes to clearing valacyclovir from your body. Between 60% and 90% of the drug is excreted through the kidneys after it converts to its active form, acyclovir. When the kidneys can’t clear the drug fast enough, crystals can form in the kidney tubules, or the tissue between the tubules can become inflamed. Both of these can lead to acute kidney injury.
This is rare at standard suppressive doses, but when it happens, it can be dramatic. Case reports describe patients whose creatinine (a waste product the kidneys filter) jumped from a normal level of around 1.0 to nearly 8.0, indicating a severe drop in kidney function. The reassuring part: most patients see their kidney function return to normal within about two weeks of stopping the medication.
Your risk goes up if you’re dehydrated, taking other medications that stress the kidneys, or already have some degree of kidney impairment. Older adults are especially vulnerable because kidney function naturally declines with age, often without obvious symptoms. The FDA prescribing information specifically flags elderly patients as more likely to experience kidney problems and recommends dose reductions based on how well the kidneys are filtering.
Neurological Side Effects
Valacyclovir-associated neurotoxicity is rare but serious. It happens when a byproduct of the drug accumulates in the blood and spinal fluid, where it interferes with normal brain cell function. Symptoms typically appear within 72 hours of starting the medication or after a dose increase, rather than creeping in slowly over months.
The most commonly reported neurological symptoms include confusion, agitation, slurred speech, hallucinations (including unusual tactile sensations like a feeling of “brain itching”), and in severe cases, seizures or a more profound state of brain dysfunction called encephalopathy. A small number of patients have also reported dissociative symptoms, feeling detached from their own body.
These neurological effects are strongly tied to kidney function. When the kidneys aren’t clearing the drug efficiently, its toxic byproduct builds up and crosses into the brain. This is why neurotoxicity and kidney problems often appear together, and why older adults and people with kidney disease face the highest risk. The good news is that these symptoms are reversible once the drug is stopped and cleared from the body.
Liver Enzyme Changes
Valacyclovir can cause mild elevations in liver enzymes, which are blood markers of liver stress. In clinical studies, elevated levels of AST (one liver enzyme) were reported in up to 16% of patients, and elevated ALT (another liver enzyme) in up to 14%. Meaningful elevations, defined as more than double the upper limit of normal, occurred in roughly 2% to 4% of patients.
These elevations are usually mild and don’t cause symptoms. Postmarketing reports include cases of hepatitis and other liver function abnormalities, but frank liver damage from valacyclovir is uncommon. If your baseline liver function tests are normal before starting therapy, the current consensus is that routine repeat testing isn’t needed unless symptoms develop.
A Rare Blood Disorder in Immunocompromised Patients
One serious complication, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), has been linked to valacyclovir in people with weakened immune systems. This includes patients with HIV or those who have received a bone marrow or kidney transplant. TTP/HUS involves abnormal blood clotting in small vessels throughout the body and can damage the kidneys, brain, and other organs. This complication has not been a meaningful risk for people with healthy immune systems taking standard doses.
Drug Interactions That Raise Risk
Certain medications can amplify valacyclovir’s side effects by competing for kidney clearance or adding their own kidney stress. The most notable interactions include other antiviral drugs like ganciclovir and cidofovir, as well as tenofovir (used in HIV treatment) and zidovudine. Taking any of these alongside valacyclovir increases the concentration of both drugs in the blood, raising the chance of toxicity. Other medications that are hard on the kidneys, including common over-the-counter anti-inflammatory drugs, should be used cautiously.
What Long-Term Suppressive Therapy Looks Like
Many people take valacyclovir daily for years to suppress herpes outbreaks, and the safety data on this approach is reassuring. The CDC’s treatment guidelines state that neither routine blood monitoring nor mandatory treatment breaks are necessary during long-term suppressive therapy, as long as initial blood work was normal. A British study published in a BMJ journal reached the same conclusion: check kidney function, liver enzymes, and blood counts at baseline, and if everything looks fine, no further monitoring is needed.
The CDC does recommend an annual conversation with your provider about whether to continue suppressive therapy. This isn’t because of accumulating drug toxicity. It’s because herpes outbreaks naturally become less frequent over time for many people, so the medication may eventually become unnecessary. Antiviral resistance from long-term use is uncommon in people with healthy immune systems.
Who Needs to Be More Careful
Most of valacyclovir’s serious side effects cluster in specific groups. If you’re over 65, have any degree of kidney impairment, are immunocompromised, or take other medications that affect the kidneys, your risk is meaningfully higher than average. For these groups, dose adjustments based on kidney filtration rate are standard practice, and staying well hydrated becomes especially important.
For the majority of people on suppressive therapy, a healthy adult taking 500 mg to 1 gram daily with adequate water intake, the long-term side effect profile is mild. The most common day-to-day complaints are headache and nausea, not the organ-level effects described above. The serious complications are real but rare, and nearly all of them reverse once the drug is discontinued.

